WO2001016857A3 - System and method for genomic and proteomic agricultural disease assessment via expression profile comparison - Google Patents

System and method for genomic and proteomic agricultural disease assessment via expression profile comparison Download PDF

Info

Publication number
WO2001016857A3
WO2001016857A3 PCT/US2000/023446 US0023446W WO0116857A3 WO 2001016857 A3 WO2001016857 A3 WO 2001016857A3 US 0023446 W US0023446 W US 0023446W WO 0116857 A3 WO0116857 A3 WO 0116857A3
Authority
WO
WIPO (PCT)
Prior art keywords
analysis device
analysis
expression profile
device reader
sample
Prior art date
Application number
PCT/US2000/023446
Other languages
French (fr)
Other versions
WO2001016857A2 (en
Inventor
Alex Titomirov
Original Assignee
Pluvita Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pluvita Corp filed Critical Pluvita Corp
Priority to AU78261/00A priority Critical patent/AU7826100A/en
Publication of WO2001016857A2 publication Critical patent/WO2001016857A2/en
Publication of WO2001016857A3 publication Critical patent/WO2001016857A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Abstract

A system and method of genomic and proteomic disease assessment via expression profile comparison whereby a baseline expression profiled is created by a user by depositing a biological sample on an analysis device. The biological information is read on an analysis device reader and transmitted to an analysis center where it is stored. The user deposits subsequent biological samples, which are compared to the stored sample that is originally taken. The analysis center compares the initial expression profile with subsequent expressions profiles to determine the health of the source of the sample. The biological sample can be from plants. The analysis device reader can be a wired or wireless device connected to a personal computer which in turn is connected to the Internet. In an alternate embodiment, the analysis device reader is in a cellular type telephone for wireless transmission. In yet another embodiment, the analysis device reader is in a kiosk which dispenses analysis devices and where it can be used by anyone with a credit token. Interpreted information is then returned to the appropriate person with advice on the meaning of the interpreted results, other sources of expert assistance and counseling where necessary.
PCT/US2000/023446 1999-08-27 2000-08-25 System and method for genomic and proteomic agricultural disease assessment via expression profile comparison WO2001016857A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU78261/00A AU7826100A (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic agricultural disease assessment via expression profile comparison

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US15097499P 1999-08-27 1999-08-27
US60/150,974 1999-08-27
US15879599P 1999-10-12 1999-10-12
US60/158,795 1999-10-12
US49880400A 2000-02-07 2000-02-07
US09/498,804 2000-02-07

Publications (2)

Publication Number Publication Date
WO2001016857A2 WO2001016857A2 (en) 2001-03-08
WO2001016857A3 true WO2001016857A3 (en) 2002-03-21

Family

ID=27387064

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2000/023446 WO2001016857A2 (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic agricultural disease assessment via expression profile comparison
PCT/US2000/023474 WO2001016859A2 (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic animal disease assessment via expression profile comparison
PCT/US2000/023447 WO2001016858A2 (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic human disease assessment via expression profile comparison

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/US2000/023474 WO2001016859A2 (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic animal disease assessment via expression profile comparison
PCT/US2000/023447 WO2001016858A2 (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic human disease assessment via expression profile comparison

Country Status (3)

Country Link
EP (1) EP1410299A2 (en)
AU (3) AU7077500A (en)
WO (3) WO2001016857A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1367201A (en) * 1999-10-01 2001-05-10 Orchid Biosciences, Inc. Method and system for providing genotype clinical information over a computer network
AU2064001A (en) * 1999-12-06 2001-06-12 National Center For Genome Resources System and method for metabolic profiling
AU2001278599A1 (en) * 2000-08-10 2002-02-18 Glaxo Group Limited A global electronic medicine response profile testing network
WO2002017207A2 (en) * 2000-08-23 2002-02-28 Arexis Ab System and method of storing genetic information
AU2001285615B2 (en) * 2000-09-22 2007-03-29 Cryosite Limited System and method for management of specimens
CA2387277C (en) 2001-05-25 2015-03-03 Hitachi, Ltd. Information processing system using nucleotide sequence-related information
JP4092990B2 (en) 2002-09-06 2008-05-28 株式会社日立製作所 Biological and chemical sample inspection equipment
AU2002952696A0 (en) * 2002-11-14 2002-11-28 Genomics Research Partners Pty Ltd Status determination
AU2003901196A0 (en) * 2003-03-17 2003-04-03 Commonwealth Scientific And Industrial Research Organisation Analysis method
US20060136143A1 (en) * 2004-12-17 2006-06-22 General Electric Company Personalized genetic-based analysis of medical conditions
WO2009050729A2 (en) * 2007-06-06 2009-04-23 Tata Consultancy Services Limited A mobile based advisory system and a method thereof
WO2012070056A2 (en) 2010-11-23 2012-05-31 Krisani Biosciences (P) Ltd Method and system for prognosis and treatment of diseases using portfolio of genes
KR20160118391A (en) * 2013-12-07 2016-10-11 시퀀싱닷컴 System and method for real-time personalization utilizing an individual's genomic data
CN105095623B (en) * 2014-05-13 2017-11-17 中国人民解放军总医院 Screening assays, platform, server and the system of disease biomarkers
CN111276248B (en) * 2020-01-20 2023-09-12 苏州帕诺米克生物医药科技有限公司 State determination system and electronic device

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5704366A (en) * 1994-05-23 1998-01-06 Enact Health Management Systems System for monitoring and reporting medical measurements
WO1998024212A1 (en) * 1996-11-29 1998-06-04 Micromedical Industries Limited Telemedicine system
US5827180A (en) * 1994-11-07 1998-10-27 Lifemasters Supported Selfcare Method and apparatus for a personal health network
US5878746A (en) * 1993-08-25 1999-03-09 Lemelson; Jerome H. Computerized medical diagnostic system
WO1999021118A1 (en) * 1997-10-17 1999-04-29 Pioneer Hi-Bred International, Inc. Process for physiological/agronomic/pest diagnostics using video imaging
US5935060A (en) * 1996-07-12 1999-08-10 First Opinion Corporation Computerized medical diagnostic and treatment advice system including list based processing
WO1999042558A1 (en) * 1998-02-20 1999-08-26 Nanogen, Inc. Advanced active devices and methods for molecular biological analysis and diagnostics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6055512A (en) * 1997-07-08 2000-04-25 Nortel Networks Corporation Networked personal customized information and facility services
US6397190B1 (en) * 1998-07-22 2002-05-28 Gerald E. Goetz Veterinary medication monitoring system and apparatus

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5878746A (en) * 1993-08-25 1999-03-09 Lemelson; Jerome H. Computerized medical diagnostic system
US5704366A (en) * 1994-05-23 1998-01-06 Enact Health Management Systems System for monitoring and reporting medical measurements
US5827180A (en) * 1994-11-07 1998-10-27 Lifemasters Supported Selfcare Method and apparatus for a personal health network
US5935060A (en) * 1996-07-12 1999-08-10 First Opinion Corporation Computerized medical diagnostic and treatment advice system including list based processing
WO1998024212A1 (en) * 1996-11-29 1998-06-04 Micromedical Industries Limited Telemedicine system
WO1999021118A1 (en) * 1997-10-17 1999-04-29 Pioneer Hi-Bred International, Inc. Process for physiological/agronomic/pest diagnostics using video imaging
WO1999042558A1 (en) * 1998-02-20 1999-08-26 Nanogen, Inc. Advanced active devices and methods for molecular biological analysis and diagnostics

Also Published As

Publication number Publication date
WO2001016858A3 (en) 2002-01-17
AU6939700A (en) 2001-03-26
AU7077500A (en) 2001-03-26
WO2001016857A2 (en) 2001-03-08
WO2001016859A2 (en) 2001-03-08
WO2001016859A3 (en) 2001-11-22
AU7826100A (en) 2001-03-26
WO2001016858A2 (en) 2001-03-08
EP1410299A2 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
WO2001016857A3 (en) System and method for genomic and proteomic agricultural disease assessment via expression profile comparison
Haubenberger et al. Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor
Douglas et al. Comparative validity analysis of multiple measures of violence risk in a sample of criminal offenders
Eastwood et al. Medical rehabilitation length of stay and outcomes for persons with traumatic spinal cord injury—1990–1997
Zarkin et al. The effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment
WO2001063544A3 (en) Health data collection and management system
Pelissier Gender differences in substance use treatment entry and retention among prisoners with substance use histories
Besson et al. The speed of visual recognition memory
AlHuthaifi et al. Predictors of functional outcomes in adults with traumatic spinal cord injury following inpatient rehabilitation: a systematic review
Wang et al. Integrating TTF and IDT to evaluate user intention of big data analytics in mobile cloud healthcare system
Ottenbacher et al. Comparison of logistic regression and neural network analysis applied to predicting living setting after hip fracture
WO2001001218A3 (en) Methods for obtaining and using haplotype data
Morris et al. Using wavelet-based functional mixed models to characterize population heterogeneity in accelerometer profiles: a case study
HK1057158A1 (en) Devices and methods for accessing and analyzing physiological fluid
WO2004015546A3 (en) Touch-screen applications for outpatient process automation
Grosholz et al. Assessing the relationship between physical health and inmate misconduct
Beaver et al. Social support or biosocial support? A genetically informative analysis of social support and its relation to self-control
Torrent-Sellens et al. Modeling and predicting outcomes of eHealth usage by European physicians: multidimensional approach from a survey of 9196 general practitioners
WO2013119632A1 (en) Apparatus and methods for analyzing a medical condition
Pavlova et al. Impact of tactile sensation on dexterity: a Cross-Sectional Study of Patients with impaired hand function after stroke
Mun et al. An SEM approach for the evaluation of intervention effects using pre-post-post designs
Little et al. Relationship of DUI recidivism to moral reasoning, sensation seeking, and MacAndrew alcoholism scores
Murray et al. Design and analysis issues in community trials
WO2001071636A3 (en) Personalized health profiling system and method
Wagner A Rehabilomics framework for personalized and translational rehabilitation research and care for individuals with disabilities: Perspectives and considerations for spinal cord injury

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP